Aequus Pharmaceuticals (AQS) Insider Trading & Ownership

C$0.02
-0.01 (-25.00%)
(As of 05:18 PM ET)

Aequus Pharmaceuticals (CVE:AQS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.68%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
C$106,625.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get AQS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aequus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AQS Insider Buying and Selling by Quarter

Aequus Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/30/2022Doug JanzenDirectorBuy285,000C$0.04C$11,400.00
11/20/2022Doug JanzenDirectorBuy115,000C$0.03C$3,450.00
7/25/2022Marc LustigDirectorBuy64,000C$0.07C$4,480.00
7/21/2022Marc LustigDirectorBuy4,000C$0.07C$280.00
7/19/2022Doug JanzenDirectorBuy99,000C$0.07C$6,930.00
9/1/2021Doug JanzenDirectorBuy500,000C$0.15C$72,500.00
4/27/2021Doug JanzenDirectorBuy41,000C$0.19C$7,585.00
(Data available from 1/1/2013 forward)

AQS Insider Trading Activity - Frequently Asked Questions

Who is on Aequus Pharmaceuticals's Insider Roster?

The list of insiders at Aequus Pharmaceuticals includes Doug Janzen, and Marc Lustig. Learn more on insiders at AQS.

What percentage of Aequus Pharmaceuticals stock is owned by insiders?

14.68% of Aequus Pharmaceuticals stock is owned by insiders. Learn more on AQS's insider holdings.

Which Aequus Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased AQS shares in the last 24 months: Doug Janzen (C$21,780.00), and Marc Lustig (C$4,760.00).

How much insider buying is happening at Aequus Pharmaceuticals?

Insiders have purchased a total of 567,000 AQS shares in the last 24 months for a total of C$26,540.00 bought.


More Insider Trading Tools from MarketBeat

This page (CVE:AQS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners